Urs B. Hagemann PhD

Urs Hagemann is an Aimed biologist (University of Freiburg, Germany) with Ph.D. rer. nat. in protein engineering. He has ten years of experience in the pharmaceutical industry from early drug discovery to clinical development in oncology. Since 2012, focusing on the development of targeted alpha emitting radiopharmaceuticals.